tyrosine has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Adhikari, A; Adhikari, S; Allen, JR; Alpert, EJ; Do, D; Gallagher, K; Garcia, SP; Heckman, CA; Heinäniemi, M; Hyvärinen, N; Iyer, S; Jin, AH; Kelliher, M; Langenau, DM; Laukkanen, S; Lohi, O; Loontiens, S; McCarthy, K; Moisio, S; Oksa, L; Pello, A; Ruokoranta, T; Veloso, A; Whelton, L; Yan, C; Yang, Q; Yoder, JA | 1 |
1 other study(ies) available for tyrosine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia.
Topics: Animals; Cell Line, Tumor; Child; Dasatinib; Humans; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mammals; Mechanistic Target of Rapamycin Complex 1; Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Receptors, Antigen, T-Cell; Recurrence; Signal Transduction; T-Lymphocytes; Tyrosine; Zebrafish | 2022 |